Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/44461
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Castro López-Tarruella, Enrique | en_US |
dc.contributor.author | Oset‐Gasque, M. J. | en_US |
dc.contributor.author | Cañadas, S. | en_US |
dc.contributor.author | Gimenez, G. | en_US |
dc.contributor.author | González, M. P. | en_US |
dc.date.accessioned | 2018-11-21T23:15:17Z | - |
dc.date.available | 2018-11-21T23:15:17Z | - |
dc.date.issued | 1988 | en_US |
dc.identifier.issn | 0360-4012 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/44461 | - |
dc.description.abstract | The effect of several ligands and Ca2+ ions on [3H]GABA binding to bovine adrenal medulla membranes was investigated. Without any blockade, the [3H]GABA binding showed two components, one of low affinity (Kd = 139 ± 22 nM and Bmax = 3.2 ± 0.4 pmol/mg protein) and the other of high affinity (Kd = 41 ± 6 nM and Bmax = 0.35 ± 0.26 pmol/mg protein). Muscimol specifically blocked low‐affinity sites, and ( – )baclofen blocked high‐affinity components. Ca2+ ions were strictly necessary for maximum binding to high‐affinity sites, whereas they did not significantly affect sites of the lower affinity. These results show that the bovine adrenal medulla has a GABAA receptor population of low affinity together with a GABAB receptor of high affinity. | en_US |
dc.language | eng | en_US |
dc.publisher | 0360-4012 | |
dc.relation.ispartof | Journal of Neuroscience Research | en_US |
dc.source | Journal of Neuroscience Research [ISSN 0360-4012], v. 20, p. 241-245 | en_US |
dc.subject | 320502 Endocrinología | en_US |
dc.subject | 240104 Citología animal | en_US |
dc.subject | 241003 Citología humana | en_US |
dc.subject.other | GABA receptor | en_US |
dc.subject.other | Adrenal medulla | en_US |
dc.title | GABAA and GABAB sites in bovine adrenal medulla membranes | en_US |
dc.type | info:eu-repo/semantics/article | es |
dc.type | Article | es |
dc.identifier.doi | 10.1002/jnr.490200213 | en_US |
dc.identifier.scopus | 0023821306 | - |
dc.contributor.authorscopusid | 35095882100 | - |
dc.contributor.authorscopusid | 7004173468 | - |
dc.contributor.authorscopusid | 6504022975 | - |
dc.contributor.authorscopusid | 36764277300 | - |
dc.contributor.authorscopusid | 7404553950 | - |
dc.description.lastpage | 245 | - |
dc.description.firstpage | 241 | - |
dc.relation.volume | 20 | - |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.ulpgc | Sí | es |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.fullName | Castro López-Tarruella, Enrique | - |
Colección: | Artículos |
Citas SCOPUSTM
23
actualizado el 15-dic-2024
Citas de WEB OF SCIENCETM
Citations
22
actualizado el 15-dic-2024
Visitas
57
actualizado el 04-may-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.